ROME — Rome Health is expanding its robotic surgery program to provide men with a new minimally invasive option to treat an ...

Rome Health is expanding its robotic surgery program to offer a new minimally invasive option for treating an enlarged ...

Halda Therapeutics is developing oral assets for prostate and lung cancer. The deal comes after Johnson & Johnson set an ...

Johnson & Johnson is paying $3.05 billion to acquire Halda Therapeutics, obtaining a novel cell death platform while ...

NEW HAVEN, Conn., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Halda Therapeutics announced today that it has entered into a definitive agreement pursuant to which Johnson & Johnson will acquire Halda for $3.05 ...

With rates of advanced prostate cancer on the rise, local medical experts offer advice on screenings, risks, and new ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets AI-powered ...

"Our exclusive partnership with Profound Medical marks a significant step in advancing precision prostate care across Australia and New Zealand,” commented Getz Healthcare ANZ Managing Director, Derek ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets artificial intelligence (“AI”)-powered, MRI-guided, ...

PureHealth Research's prostate health supplements address this widespread concern through evidence-based formulations that support urinary flow, comfort, and normal prostate function. The collection ...

The company scans entire proteins with CRISPR to find functional vulnerabilities, then hunts for molecules that exploit them ...

Shortly after President Trump took office, CDC officials were notified that virtually all active FACA charters covering CDC projects and programs would be revoked, effective immediately. Debra Houry, ...